The need for precision management in glaucoma moves field forward - Ophthalmology Times Europe

Genotyping and artificial intelligence are together starting to predict the progression of glaucoma in individual patients, sparing them from suboptimal treatments and side effects. Recent research efforts are exploring modifiable risk factors such as caffein…

After my first interview with glaucoma specialist Dr Anthony Khawaja, on the exciting therapeutic area of precision medicine, published in the April issue of Ophthalmology Times Europe® last year,1 I… [+11756 chars]

full article...